AdviceOne Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$491K Buy
424
+7
+2% +$8.26K 0.29% 24
2026
Q2
$500K Hold
417
– – 0.28% 22
2026
Q1
$384K Hold
417
– – 0.23% 22
2025
Q4
$448K Hold
417
– – 0.27% 20
2025
Q3
$318K Buy
417
+27
+7% +$20.1K 0.21% 29
2025
Q2
$304K Buy
390
+31
+9% +$24.1K 0.22% 25
2025
Q1
$297K Buy
359
+18
+5% +$15K 0.24% 20
2024
Q4
$263K Buy
+341
New +$282K 0.23% 21

Other funds holding LLY

AdviceOne Advisory Services's LLY Position: Q3 2026 in Review

AdviceOne Advisory Services increased its Eli Lilly (LLY) stake by 1.7% in Q3 2026, buying an estimated $8.26K and bringing the position to 424 shares worth $491K. The position accounts for 0.29% of the portfolio, ranked #24.

AdviceOne Advisory Services first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $500K in Q2 2026. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • AdviceOne Advisory Services held 424 shares of Eli Lilly worth $491K as of Q3 2026.
  • AdviceOne Advisory Services bought 7 Eli Lilly shares in Q3 2026, an estimated $8.26K.
  • Eli Lilly made up 0.29% of AdviceOne Advisory Services's portfolio in Q3 2026, its #24 holding.
  • AdviceOne Advisory Services first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • AdviceOne Advisory Services's Eli Lilly position peaked at $500K in Q2 2026.
  • 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on AdviceOne Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.